Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors

Chatal Jean-Francois, Davodeau Francois, Cherel Michel, Barbet Jacques

Year : 2009| Volume: 5| Issue : 9 | Page no: 36-40

   This article has been cited by
1 Emerging Trends for Radioimmunotherapy in Solid Tumors
Maneesh Jain,Suprit Gupta,Sukhwinder Kaur,Moorthy P. Ponnusamy,Surinder K. Batra
Cancer Biotherapy & Radiopharmaceuticals. 2013; 28(9): 639
[Pubmed]  [Google Scholar] [DOI]
2 Radiofrequency Ablation Before Intratumoral Injection of131I-chTNT Improves the Tumor-to-Normal Tissue Ratio in Solid VX2Tumor
Shu-Guang Zheng,Hui-Xiong Xu,Ming-De Lu,Dian-Chao Yue,Xiao-Yan Xie,Guang-Jian Liu
Cancer Biotherapy & Radiopharmaceuticals. 2013; 28(10): 725
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation of strained alkynes for Cu-free click reaction in live mice
S.M. van den Bosch,R. Rossin,P. Renart Verkerk,W. ten Hoeve,H.M. Janssen,J. Lub,M.S. Robillard
Nuclear Medicine and Biology. 2013; 40(3): 415
[Pubmed]  [Google Scholar] [DOI]
4 Highly Reactivetrans-Cyclooctene Tags with Improved Stability for Diels–Alder Chemistry in Living Systems
Raffaella Rossin,Sandra M. van den Bosch,Wolter ten Hoeve,Marco Carvelli,Ron M. Versteegen,Johan Lub,Marc S. Robillard
Bioconjugate Chemistry. 2013; 24(7): 1210
[Pubmed]  [Google Scholar] [DOI]
5 Bispecific Her2 × cotinine antibody in combination with cotinine–(histidine)2–iodine for the pre-targeting of Her2-positive breast cancer xenografts
Soomin Yoon,Yun-Hee Kim,Se Hun Kang,Seok-Ki Kim,Hwa Kyoung Lee,Hyori Kim,Junho Chung,In-Hoo Kim
Journal of Cancer Research and Clinical Oncology. 2013;
[Pubmed]  [Google Scholar] [DOI]
6 Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Robert J. Gillies,Daniel Verduzco,Robert A. Gatenby
Nature Reviews Cancer. 2012; 12(7): 487
[Pubmed]  [Google Scholar] [DOI]
7 Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Gillies, R.J., Verduzco, D., Gatenby, R.A.
Nature Reviews Cancer. 2012; 12(7): 487-493
[Pubmed]  [Google Scholar]
8 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland
Beck, A., Wurch, T., Reichert, J.M.
mAbs. 2011; 3(2): 111-134
[Pubmed]  [Google Scholar]
9 6thAnnual European Antibody Congress 2010
Alain Beck,Thierry Wurch
mAbs. 2011; 3(2): 111
[Pubmed]  [Google Scholar] [DOI]
10 Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer
G. M. de Jong, R. P. Bleichrodt, A. Eek, W. J. G. Oyen, O. C. Boerman, T. Hendriks
British Journal of Surgery. 2011; 98(3): 436
[HTML Full text]  [Google Scholar] [DOI]
11 A rapid microwave-assisted procedure for easy access to Npolydentate ligands for potential application in α-RIT
Mével, M., Bodio, E., Grosjean, S., Montavon, G., Meslin, J.-C., Julienne, K., Deniaud, D.
Synlett. 2010; 8(G04610ST): 1215-1218
[Pubmed]  [Google Scholar]
12 New antibody conjugates in cancer therapy
Govindan, S.V., Goldenberg, D.M.
TheScientificWorldJournal. 2010; 10: 2070-2089
[Pubmed]  [Google Scholar]
13 Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies
Boudousq, V., Ricaud, S., Garambois, V., Bascoul-Mollevi, C., Boutaleb, S., Busson, M., Quenet, F., (...), Pouget, J.-P.
Journal of Nuclear Medicine. 2010; 51(11): 1748-1755
[Pubmed]  [Google Scholar]


Read this article